FR2879458B1 - Sulfamides et sulfinimides fluores - Google Patents

Sulfamides et sulfinimides fluores

Info

Publication number
FR2879458B1
FR2879458B1 FR0413676A FR0413676A FR2879458B1 FR 2879458 B1 FR2879458 B1 FR 2879458B1 FR 0413676 A FR0413676 A FR 0413676A FR 0413676 A FR0413676 A FR 0413676A FR 2879458 B1 FR2879458 B1 FR 2879458B1
Authority
FR
France
Prior art keywords
sulfinimides
sulfamides
fluorinated
fluorinated sulfamides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0413676A
Other languages
English (en)
Other versions
FR2879458A1 (fr
Inventor
Hubert Blancou
Franck Guillen
Zohra Benfodda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
S3F CHIMIE SOC CHIMIQUE DE FAB
Centre National de la Recherche Scientifique CNRS
Universite Montpellier 2 Sciences et Techniques
Original Assignee
S3F CHIMIE SOC CHIMIQUE DE FAB
Centre National de la Recherche Scientifique CNRS
Universite Montpellier 2 Sciences et Techniques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S3F CHIMIE SOC CHIMIQUE DE FAB, Centre National de la Recherche Scientifique CNRS, Universite Montpellier 2 Sciences et Techniques filed Critical S3F CHIMIE SOC CHIMIQUE DE FAB
Priority to FR0413676A priority Critical patent/FR2879458B1/fr
Priority to EP05850551A priority patent/EP1833474A1/fr
Priority to PCT/FR2005/003202 priority patent/WO2006067330A1/fr
Priority to US11/793,412 priority patent/US20080015255A1/en
Publication of FR2879458A1 publication Critical patent/FR2879458A1/fr
Application granted granted Critical
Publication of FR2879458B1 publication Critical patent/FR2879458B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR0413676A 2004-12-21 2004-12-21 Sulfamides et sulfinimides fluores Expired - Fee Related FR2879458B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR0413676A FR2879458B1 (fr) 2004-12-21 2004-12-21 Sulfamides et sulfinimides fluores
EP05850551A EP1833474A1 (fr) 2004-12-21 2005-12-20 Compositions pharmaceutiques a base de sulfamides et sulfinimides fluores
PCT/FR2005/003202 WO2006067330A1 (fr) 2004-12-21 2005-12-20 Compositions pharmaceutiques a base de sulfamides et sulfinimides fluores
US11/793,412 US20080015255A1 (en) 2004-12-21 2005-12-20 Pharmaceutical Compositions Based on Fluorinated Sulphamides and Sulphinimides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0413676A FR2879458B1 (fr) 2004-12-21 2004-12-21 Sulfamides et sulfinimides fluores

Publications (2)

Publication Number Publication Date
FR2879458A1 FR2879458A1 (fr) 2006-06-23
FR2879458B1 true FR2879458B1 (fr) 2007-07-20

Family

ID=34952918

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0413676A Expired - Fee Related FR2879458B1 (fr) 2004-12-21 2004-12-21 Sulfamides et sulfinimides fluores

Country Status (4)

Country Link
US (1) US20080015255A1 (fr)
EP (1) EP1833474A1 (fr)
FR (1) FR2879458B1 (fr)
WO (1) WO2006067330A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2297070A2 (fr) * 2008-07-03 2011-03-23 Bayer Schering Pharma Aktiengesellschaft Composés et procédés pour la production d agents radiopharmaceutiques
CN112239453A (zh) * 2019-07-16 2021-01-19 杉杉新材料（衢州）有限公司 一种酰基磺酸酯类化合物的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4031036A (en) * 1975-06-09 1977-06-21 Minnesota Mining And Manufacturing Company Use of bis(fluoroaliphaticsulfonyl) imides in cationic polymerization
US4824866A (en) * 1987-02-02 1989-04-25 Riker Laboratories, Inc. Anti-glaucoma use of trifluoromethanesulfonamide
CA2248244C (fr) * 1996-12-30 2010-05-11 Hydro-Quebec Sels d'anions heterocycliques aromatiques, et leurs utilisations comme materiaux a conduction ionique
CA2283589A1 (fr) * 1997-03-11 1998-09-17 New Japan Chemical Co., Ltd. Complexes a terre rare
AUPP609198A0 (en) * 1998-09-22 1998-10-15 Curtin University Of Technology Use of non-peptidyl compounds for the treatment of insulin related ailments
FR2823205B1 (fr) * 2001-04-09 2003-06-13 Centre Nat Rech Scient Composition a base d'un compose amine et de bifluorure d'ammonium et son utilisation
US7402595B2 (en) * 2002-02-13 2008-07-22 Takeda Pharmaceutical Company Limited JNK inhibitor

Also Published As

Publication number Publication date
WO2006067330A1 (fr) 2006-06-29
EP1833474A1 (fr) 2007-09-19
WO2006067330B1 (fr) 2006-09-28
FR2879458A1 (fr) 2006-06-23
US20080015255A1 (en) 2008-01-17

Similar Documents

Publication Publication Date Title
CY2019034I2 (el) 4-φαινυλαμινο-κιναζολιν-6-υλ-αμιδια
ATE414693T1 (de) Neuartige cis-imidazoline
DE602005026030D1 (de) Blutdruckmessgerät
ATE520680T1 (de) Hiv-hemmende 5-heterocyclylpyrimidine
ATE392425T1 (de) Thiazolyl-dihydro-indazole
ATE459633T1 (de) Makrolide
DE112005000809A5 (de) Wankstabilisierungseinrichtung
AT500198B1 (de) Ladewagen
ATE389633T1 (de) Omega-phenyloctanamide
DE112005000794T5 (de) Urethanspritzpistolenanordnung
AT500249A3 (de) Scheibenegge
FR2879458B1 (fr) Sulfamides et sulfinimides fluores
SE0400530L (sv) Förfarande
FR2865955B1 (fr) Etabli-treteau-polyvalent et pliable
DE112005001019A5 (de) Kunststoffschraubverschlusskappe
ITMI20031514A1 (it) Ombrello
AT7802U3 (de) Parfum-zerstäuber
ATA9982004A (de) Tiefbohrbrunnen
SE0400613D0 (sv) New compounds and use thereof
FI20040919A0 (fi) Rullausmenetelmä ja sovitelma
AT500956B8 (de) Personenschleuse
SE0402600D0 (sv) Novel use
SE0400092D0 (sv) Novel use
SE0402599D0 (sv) Novel use
SE0402595D0 (sv) Novel use

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

ST Notification of lapse

Effective date: 20200910